Researchers at the University of California, San Francisco (UCSF), are developing an implantable artificial kidney that can closely replicate the functions of real kidneys. The Kidney Project is raising money to complete preclinical studies of the device modules and to build full-scale prototypes for the first round of human studies. Initial clinical trials on the individual modules are expected to begin early next year. Testing of a working prototype of the bioartificial kidney is slated for 2020.
More than 40% of sleep apnea sufferers refuse to wear CPAP machines, because of noise, mask irritation and claustrophobia. Neuromodulation is an alternative!
An implant that is inserted during minimally-invasive surgery stimulates certain airways and help with breathing. According to Cleveland Clinic's Sleep Disorder Center, the system has not caused any serious complications in clinical testing
According to a recent Washington Examiner article, one third of the US population suffers from chronic pain. Per the same article, 90 percent of doctors practicing medicine in America today do not know how to treat chronic pain. In 2015, 33 thousand lives were lost to opioid-related causes, and 45 percent of those deaths involved a prescription.
Not surprisingly, recently President Trump has declared Opioid Epidemic a Public Health Crisis.
Electronic neurostimulators with little or no side effects can be the answer to many problem, yet, surprisingly less than 100 thousand chronic pain sufferers can receive Spinal Cord Stimulation (SCS) per year.
New advanced neurostimulation devices, including the ones that can be fully programmed for customized personal care can help combat the opioid crises quickly and affordably. Further, programmable neurostimulators promise to accelerate medical research in areas of other neurological disorders.
The bottom line is, with the fully programmable neurostimulators, the solution to opioid crisis and new advanced therapies for many neurological disorders are much closer than we think.